UBS Group’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-34,530
| Closed | -$6.56K | – | 9040 |
|
|
2023
Q2 | $6.56K | Buy |
34,530
+34,155
| +9,108% | +$6.49K | ﹤0.01% | 6277 |
|
|
2023
Q1 | $128 | Hold |
375
| – | – | ﹤0.01% | 8097 |
|
|
2022
Q4 | $120 | Hold |
375
| – | – | ﹤0.01% | 9178 |
|
|
2022
Q3 | $0 | Sell |
375
-550
| -59% | – | ﹤0.01% | 10105 |
|
|
2022
Q2 | $0 | Buy |
925
+375
| +68% | – | ﹤0.01% | 10117 |
|
|
2022
Q1 | $1K | Hold |
550
| – | – | ﹤0.01% | 8978 |
|
|
2021
Q4 | $1K | Sell |
550
-2,783
| -83% | -$5.06K | ﹤0.01% | 8976 |
|
|
2021
Q3 | $7K | Sell |
3,333
-1,889
| -36% | -$3.97K | ﹤0.01% | 7214 |
|
|
2021
Q2 | $8K | Sell |
5,222
-13,864
| -73% | -$21.2K | ﹤0.01% | 7169 |
|
|
2021
Q1 | $42K | Buy |
19,086
+7,579
| +66% | +$16.7K | ﹤0.01% | 5724 |
|
|
2020
Q4 | $28K | Buy |
11,507
+9,898
| +615% | +$24.1K | ﹤0.01% | 5698 |
|
|
2020
Q3 | $4K | Sell |
1,609
-12,120
| -88% | -$30.1K | ﹤0.01% | 6577 |
|
|
2020
Q2 | $49K | Buy |
13,729
+12,597
| +1,113% | +$45K | ﹤0.01% | 5045 |
|
|
2020
Q1 | $3K | Sell |
1,132
-1,021
| -47% | -$2.71K | ﹤0.01% | 6618 |
|
|
2019
Q4 | $5K | Sell |
2,153
-972
| -31% | -$2.26K | ﹤0.01% | 6531 |
|
|
2019
Q3 | $6K | Sell |
3,125
-1,944
| -38% | -$3.73K | ﹤0.01% | 6470 |
|
|
2019
Q2 | $7K | Sell |
5,069
-1,828
| -27% | -$2.52K | ﹤0.01% | 6391 |
|
|
2019
Q1 | $14K | Sell |
6,897
-5,050
| -42% | -$10.3K | ﹤0.01% | 5774 |
|
|
2018
Q4 | $16K | Buy |
11,947
+2,107
| +21% | +$2.82K | ﹤0.01% | 6041 |
|
|
2018
Q3 | $24K | Buy |
9,840
+5,717
| +139% | +$13.9K | ﹤0.01% | 5793 |
|
|
2018
Q2 | $14K | Buy |
4,123
+2,986
| +263% | +$10.1K | ﹤0.01% | 6034 |
|
|
2018
Q1 | $5K | Sell |
1,137
-3,098
| -73% | -$13.6K | ﹤0.01% | 6364 |
|
|
2017
Q4 | $14K | Sell |
4,235
-888
| -17% | -$2.94K | ﹤0.01% | 5854 |
|
|
2017
Q3 | $19K | Sell |
5,123
-21,968
| -81% | -$81.5K | ﹤0.01% | 5599 |
|
|
2017
Q2 | $119K | Buy |
27,091
+12,573
| +87% | +$55.2K | ﹤0.01% | 4183 |
|
|
2017
Q1 | $53K | Buy |
14,518
+976
| +7% | +$3.56K | ﹤0.01% | 4591 |
|
|
2016
Q4 | $36K | Buy |
+13,542
| New | +$36K | ﹤0.01% | 5172 |
|
|
2016
Q3 | – | Sell |
-81
| Closed | – | – | 6906 |
|
|
2016
Q2 | $0 | Buy |
81
+4
| +5% | – | ﹤0.01% | 6970 |
|
|
2016
Q1 | $0 | Buy |
+77
| New | – | ﹤0.01% | 6940 |
|
|
2015
Q4 | – | Sell |
-697
| Closed | -$2K | – | 7057 |
|
|
2015
Q3 | $2K | Sell |
697
-568
| -45% | -$1.63K | ﹤0.01% | 6612 |
|
|
2015
Q2 | $2K | Sell |
1,265
-1,510
| -54% | -$2.39K | ﹤0.01% | 6573 |
|
|
2015
Q1 | $2K | Sell |
2,775
-28,175
| -91% | -$20.3K | ﹤0.01% | 6456 |
|
|
2014
Q4 | $12K | Buy |
+30,950
| New | +$12K | ﹤0.01% | 5917 |
|